重庆智翔金泰生物制药股份有限公司关于参加2025年半年度科创板创新药行业集体业绩说明会的公告

Core Viewpoint - The company, Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd., will participate in the 2025 semi-annual performance briefing for the innovative drug industry on September 16, 2025, to address investor concerns and provide insights into its financial performance and operational results for the first half of 2025 [2][3][7]. Group 1: Event Details - The performance briefing will be held on September 16, 2025, from 15:00 to 17:00 [4][5]. - The event will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [4][6]. - Investors can log in to the Shanghai Stock Exchange Roadshow Center to participate and submit questions prior to the event [6]. Group 2: Participation Information - Investors are encouraged to submit questions by September 15, 2025, at 16:00 through the "Pre-Question Collection" section on the Roadshow Center website [2][6]. - The company will respond to commonly asked questions during the briefing [3][6]. - Contact information for inquiries includes the board office's phone number and email address [6].